94 related articles for article (PubMed ID: 7334719)
41. [Cell mediated immunity against tubular basement membranes in children with glomerular disease (author's transl)].
Lubec G
Wien Klin Wochenschr; 1977 Oct; 89(20):704-6. PubMed ID: 930102
[TBL] [Abstract][Full Text] [Related]
42. Current management of the nephrotic syndrome in childhood with emphasis on the role of cyclophosphamide.
Kelsch RC; Oliver WJ
Mich Med; 1972 Dec; 71(35):999-1003. PubMed ID: 4636891
[No Abstract] [Full Text] [Related]
43. [Management of steroid resistant nephrotic syndrome].
Sanjo T; Ono S
Nihon Rinsho; 1977 Jun; 35(6):2182-9. PubMed ID: 916234
[No Abstract] [Full Text] [Related]
44. Cyclophosphamide therapy in idiopathic nephrotic syndrome--a new treatment.
Dundon S; Carroll R; Dunleavy M; Raftery J
J Ir Med Assoc; 1971 May; 64(411):243-6. PubMed ID: 5578246
[No Abstract] [Full Text] [Related]
45. "Long term use of cyclophosphamide in nephrotic syndrome".
Choudhary VP
Indian Pediatr; 1978 Apr; 15(4):369. PubMed ID: 711307
[No Abstract] [Full Text] [Related]
46. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
Pennisi AJ; Grushkin CM; Lieberman E
Pediatrics; 1976 Jun; 57(6):948-51. PubMed ID: 934751
[TBL] [Abstract][Full Text] [Related]
47. [Treatment of steroid-resistant nephrotic syndrome. Physiopathology and treatment in childhood (author's transl)].
Okada T
Nihon Jinzo Gakkai Shi; 1975 May; 17(5):341-6. PubMed ID: 1241024
[No Abstract] [Full Text] [Related]
48. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
de Moor R; de Jong M; Monnens L
Ned Tijdschr Geneeskd; 1992 May; 136(18):876-80. PubMed ID: 1589052
[TBL] [Abstract][Full Text] [Related]
49. Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.
Drummond KN; Hillman DA; Marchessault JH; Feldman W
Can Med Assoc J; 1968 Mar; 98(11):524-31. PubMed ID: 5643296
[No Abstract] [Full Text] [Related]
50. [Cyclophosphamide therapy of nephrotic syndrome in childhood].
Krepler P; Rosenkranz A; Obiditsch-Mayer I; Stockinger L; Schatz H; Fritzsche H
Arch Kinderheilkd; 1970; 181(3):268-82. PubMed ID: 4922851
[No Abstract] [Full Text] [Related]
51. Immunosuppressive therapy.
Winkelstein A; Segel D; Stolzer BL; Fogel M; Shadduck RK; Lewis M
Am J Med Sci; 1973 Feb; 265(2):92-108. PubMed ID: 4736193
[No Abstract] [Full Text] [Related]
52. [Combined treatment with corticosteroids and cyclophosphamide in the nephrotic syndrome in children].
Chaimowitz S; Surasky M; Levi J; Benderly A
Harefuah; 1972 Sep; 83(6):234-6. PubMed ID: 4650395
[No Abstract] [Full Text] [Related]
53. Long term prognosis of the nephrotic syndrome in childhood.
Schärer K; Minges U
Clin Nephrol; 1973; 1(3):182-7. PubMed ID: 4783717
[No Abstract] [Full Text] [Related]
54. [Studies on the role of IgE in nephrotic syndrome (author's transl)].
Ryuge J
Nihon Jinzo Gakkai Shi; 1979 Sep; 21(9):1007-20. PubMed ID: 522303
[No Abstract] [Full Text] [Related]
55. [Relationship between proteinase inhibitory activity of plasma alpha 2-macroglobulin and depressed cell immunity in idiopathic nephrotic syndrome].
Asami T; Nisihara T; Hayashi M; Sakai K
Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):935-41. PubMed ID: 2468803
[No Abstract] [Full Text] [Related]
56. [Studies on the fibrinolytic therapy in the patients with nephrotic syndrome (author's transl)].
Shibata M; Shimizu K; Kishi T; Kobayashi K; Sakai H; Sugiyama H; Oguri M
Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1197-207. PubMed ID: 6450847
[No Abstract] [Full Text] [Related]
57. [Study on the efficacy of azapropazone--a new nonsteroidal antiinflammatory drug in various forms of renal diseases (author's transl)].
Kaburagi T; Yokoyama S; Mitsunami K; Hanyu I; Takayama S
Nihon Jinzo Gakkai Shi; 1977 Jun; 19(6):421-40. PubMed ID: 926434
[No Abstract] [Full Text] [Related]
58. [Studies of plasma active and inactive renins in patients with nephrotic syndrome. Part V. Relationships between plasma renins, pathological findings and therapeutic response in patients with nephrotic syndrome (author's transl)].
Tsai TJ
Taiwan Yi Xue Hui Za Zhi; 1981 Nov; 80(11):1145-51. PubMed ID: 7035611
[No Abstract] [Full Text] [Related]
59. Cyclophosphamide pulse therapy in frequently relapsing nephrotic syndrome.
Gandhi R; Thomas C
Nephron; 1990; 55(4):444. PubMed ID: 2392204
[No Abstract] [Full Text] [Related]
60. Proceedings: Long-term stability of remission in the nephrotic syndrome after treatment with cyclophosphamide.
Chantler C; Cameron JS; White RH; Ogg CS
Arch Dis Child; 1974 Oct; 49(10):823. PubMed ID: 4429383
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
